Antibiotics

It is a tryptomycin antibiotic produced by the strain of Streptomyces avellaneus 02-3. It inhibits P388 murine leukemia cells with IC50 of 12 μg/mL.

It is a tryptomycin antibiotic produced by the strain of Streptomyces avellaneus 02-3. It inhibits P388 murine leukemia cells with IC50 of 0.60 μg/mL.

It is produced by the strain of Streptomyces sp. 2-11. It can inhibit the proliferation of splenic lymphocytes induced by Concanavalin A in mice.

It is produced by the strain of Actinomadura sp. 937ZB-1. It has an inhibitory effect on the Angiotensin I converting enzyme.

It is produced by the strain of Actinomadura sp. 937ZB-1. It has an inhibitory effect on the Angiotensin I converting enzyme.

Antibiotic 49A is a quinone antibiotic produced by the strain of Streptomyces flavogriseus 49. It has anti-gram-positive bacteria and gram-negative bacteria activity.

It is an aminoglycoside antibiotic produced by the strain of Micromonospora inyoensis. It has broad-spectrum antimicrobial activity.

It is a dimeric aminoglycoside antibiotic produced by the strain of Micromonospora inyoensis.

It is an aminoglycoside antibiotic produced by the strain of Micromonospora inyoensis. It has broad-spectrum antimicrobial activity.

It is produced by the strain of Micromonospora inyoensis. It has activity against gram-positive and gram-negative bacteria.

It is a heptaene macrolide antibiotic produced by the strain of Actinoplanes caeruleus. It has anti-fungal and yeast activity.

It is a heptaene macrolide antibiotic produced by the strain of Actinoplanes caeruleus. It has anti-fungal and yeast activity.

It is a heptaene macrolide antibiotic produced by the strain of Actinoplanes caeruleus. It has anti-fungal and yeast activity.

It is produced by the strain of Actinomyces sp.

It is produced by the strain of Amycolata autotrophica. It has anti-gram-positive bacteria (MIC is 0.04-0.12 μg/mL) and weak anti-Saccharomyces cerevisiae (MIC is 100 μg/mL) activity.

It is a 3-α-hydroxysteroid dehydrogenase inhibitor produced by the strain of Strptomyces sp. HKI 0231. It can inhibit 3-α-hydroxysteroid dehydrogenase with IC50 of 10.5 μg/mL. It has weak antimicrobial and antifungal activity (MIC is less than 100 μg/mL).

It is a 3-α-hydroxysteroid dehydrogenase inhibitor produced by the strain of Strptomyces sp. HKI 0231. It can inhibit 3-α-hydroxysteroid dehydrogenase with IC50 of 2.5 μg/mL. It has weak antimicrobial and antifungal activity (MIC is less than 100 μg/mL).

It is a macrolide antibiotic produced by the strain of Streptomyces sp. SNUS-9011-250. It has weak activity against gram-positive bacteria with MIC of 12.5-25.0 μg/mL.

It is a peptide antibiotic produced by the strain of Bacillus circulans 333-25. It has anti-gram-positive and gram-negative bacteria activity, but no effect on pseudomonas aeruginosa. It inhibits E. coli and Klebsiella pneumoniae with IC50 of 0.95 mg/kg (Mice, subcutaneous).

It is an aminoglycoside antibiotic produced by the strain of Micromonospora sagamiensis G-477. It has weak activity against gram-positive and gram-negative bacteria.